81-Year

News Highlights

Katsumi Takasu, director of “Takasu Clinic” (81), a plastic surgery clinic, confessed about his cancer treatment, stating, “There are no more options, I’ve realized my cancer cannot be cured.” He explicitly stated, “I will not undergo life-prolonging treatment,” and indicated his intention to spend his remaining time with family and friends. The frank words of Dr. Takasu, who has long led the aesthetic medicine industry, have sent shockwaves through many medical professionals.

M&A Medical Editorial Department’s Perspective

The news regarding Dr. Takasu’s (81) cancer treatment highlights the dual challenges faced by healthcare institution managers, especially elderly directors and chairpersons: “their own health issues” and “business continuity.” Even for a renowned medical institution like Takasu Clinic, the reality is that the director’s individual health status can directly impact the survival of the business. In the event of the director’s sudden passing or long-term medical leave, business succession becomes extremely difficult if there is no successor. In this particular case, Dr. Takasu himself has determined that there are “no more options.” However, for many medical institutions, it is essential to concretely consider business continuity options, including third-party succession, before their own health issues become apparent, in order to protect patients and employees. Especially for medical corporations where a successor cannot be found or family succession is difficult, early collaboration with specialized M&A intermediaries is key to avoiding the worst-case scenario of closure or bankruptcy.

Points Highlighted by This News

• The reality that the health issues of the 81-year-old Dr. Takasu himself can become an urgent issue for business continuity.
• The risk that even for a renowned clinic, the director’s individual health status directly impacts business survival.
• The importance of establishing a Business Continuity Plan (BCP) before reaching a situation of “no more options.”
• The necessity for medical corporations without successors to consider early third-party succession to avoid closure or bankruptcy.

Practical Questions Arising from This News

• Is Dr. Takasu discussing the business continuity of his clinic with anyone in preparation for his declining health?
• In a large-scale medical corporation like Takasu Clinic, who makes decisions and what system is in place to continue operations in the event of the director’s individual health issues?
• If Dr. Takasu decides to abandon business continuity, what options can be considered to minimize the impact on patients and employees?

If You Feel “Should I Consult Too?”

Medical institution managers who are concerned about their own health status or are struggling with business continuity due to a lack of successors should view this news not as something unrelated to them. Like Dr. Takasu, objectively assessing one’s own situation and seeking the best path forward can be considered the final responsibility of a manager. By first consulting with specialists in medical M&A, you can learn about options such as third-party succession and M&A, and take the first step towards concrete consideration. Early consultation opens the door to a better future.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success-fee basis, as an M&A support institution certified by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultations are available here.